Unknown PHASE2 INTERVENTIONAL 2-arm NCT04173390

PREemptive Analgesia With preGABAlin in HEART Surgery (PREGABA-HEART)

Preemptive Analgesia With Pregabalin in Heart Surgery: a Randomized Clinical Trial

Sponsor: InCor Heart Institute

Interventions Placebo oral tablet Pregabalin 150mg

Updated 7 times since 2019 Last updated: Feb 20, 2021 Started: Mar 1, 2021 Primary completion: Dec 31, 2021 Completion: Nov 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Postoperative Pain and is currently ongoing. InCor Heart Institute leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Dec 2023 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Mar 2021 — Dec 2023 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE2

▶ Show 2 earlier versions

Mar 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2
Dec 2019 — Mar 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

InCor Heart Institute

Data source: InCor Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Campina Grande, Brazil
• João Pessoa, Brazil